MCCLUNG DAVID MARK (EVP Chief Business Officer) reported 1 transaction at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/29/2023ACC: 0001209191-23-047586
Officer· EVP Chief Business Officer
Since May 2020
-1.93K
Net shares
Net seller
$1.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.93K
Price / share
$0.77
Trade value
$1.48K
% of position
0.9%
8/25/2023
216.32K→214.40K
Total
Net shares
−1.93K
Net value
-$1.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2023 | F · Tax Withholding | −1.93K | $0.77 | $1.48K | 0.9% | 216.32K | 214.40K |
| Total | −1.93K | -$1.48K | ||||||
Derivative Transactions0
No derivative transactions reported